A single line often inverts meaning once you see what it
answers, so neighbouring messages are always shown.
-
Nice to meet you, Jim, albeit virtually. I will get back to you with a name shortly. And Cliff - thanks again for the call.
-
Nice to meet you, Jim, albeit virtually. I will get back to you with a name shortly. And Cliff - thanks again for the call. atricia (NIH/NIAID) [€] ay c 7 >; Penny >; Jim Neaton a > atricia (NIH/NIAID) [E]" || > -- lo >, Mike Poole P| I > Dr. Fauci \IIH/NIAID) [E]" >,Mike Poole Dr. Fauci
-
Nice to meet you, Jim, albeit virtually. I will get back to you with a name shortly. And Cliff - thanks again for the call.
-
Dear Cliff and Jim, Greetings! I hope this weekend finds you with at least a moment to relax. By way of this email, I would like to introduce you to Jintanat Ananworanich. She is a pediatrician and immunologist, currently co-leading our RSV monoclonal antibody program among others. She has much clinical trial experience, particularly in LMICs. She declares she has a some additional bandwidth and would love to join you on the weekly team calls and help in any way she can. I will leave it to the three of you to coordinate from here. Best, Penny
-
2020-04-18 18:27
H. Clifford Lane
Penny - We are very happy to have Jintanat join the calls. Jintanat - nice to have a chance to work with you again. Sorry it is under these circumstances. Jim will send the meeting invites. Cliff On Apr 18, 2020, at 5:43 PM, Penny Heaton @gatesmri.org> wrote: Dear Cliff and Jim, Greetings! I hope this weekend finds you with at least a moment to relax. By way of this email, I would like to introduce you to Jintanat Ananworanich. She is a pediatrician and immunologist, currently co-leading our RSV monoclonal antibody program among others. She has much clinical trial experience, particularly in LMICs. She declares she has a some additional bandwidth and would love to join you on the weekly team calls and help in any way she can. I will leave it to the three of you to coordinate from here. Best, Penny
-
Attention: This message was sent from an external domain. Thanks for the introduction Penny, and nice to meet you Jintanat. Look forward to talking to you on Wednesday and working on the protocols with you. Jim On Sat, Apr 18, 2020 at 4:43 PM Penny Heaton @gatesmri.org> wrote: Dear Cliff and Jim, nt to relax. ician and immunologist, iical trial experience, din you on the weekly [ Trevor Mundel >; Conrad, >; Mike Poole >; Jim Neaton Il get back to you with a name shortly. i > 1 PM >; Penny atricia (NIH/NIAID) [E] > c >; Jim Neaton ay atricia (NIH/NIAID) [E]" Greetings! I hope this weekend finds you with at least a moment to relax. By way of this email, I would like to introduce you to Jintanat Ananworanich. She is a pediatrician and immunologist, currently co-leading our RSV monoclonal antibody program among others. She has much clinical trial experience, particularly in LMICs. She declares she has a some additional bandwidth and would love to join you on the weekly team calls and help in any way she can. I will leave it to the three of you to coordinate from here. Best, Penny
-
Attention: This message was sent from an external domain. Thanks for the introduction Penny, and nice to meet you Jintanat. Look forward to talking to you on Wednesday and working on the protocols with you. Jim On Sat, Apr 18, 2020 at 4:43 PM Penny Heaton @gatesmri.org> wrote: Dear Cliff and Jim, Greetings! I hope this weekend finds you with at least a moment to relax. By way of this email, I would like to introduce you to Jintanat Ananworanich. She is a pediatrician and immunologist, currently co-leading our RSV monoclonal antibody program among others. She has much clinical trial experience, particularly in LMICs. She declares she has a some additional bandwidth and would love to join you on the weekly team calls and help in any way she can. I will leave it to the three of you to coordinate from here. Best, Penny
-
I think Mark knows her well. She used to work with Praphan and Kiat. On Apr 18, 2020, at 7:10 PM, Jim Neaton @umn.edu> wrote: Thanks for the introduction Penny, and nice to meet you Jintanat. Look forward to talking to you on Wednesday and working on the protocols with you. Jim On Sat, Apr 18, 2020 at 4:43 PM Penny Heaton @gatesmri.org> wrote: Dear Cliff and Jim, Greetings! I hope this weekend finds you with at least a moment to relax. By way of this email, I would like to introduce you to Jintanat Ananworanich. She is a pediatrician and immunologist, currently co-leading our RSV monoclonal antibody program among others. She has much clinical trial experience, particularly in LMICs. She declares she has a some additional bandwidth and would love to join you on the weekly team calls and help in any way she can. I will leave it to the three of you to coordinate from here. Best, Penny
-
I recognize the name - was she involved in ESPRIT? On Sat, Apr 18, 2020 at 6:12 PM Lane, Cliff (NIH/NIAID) [E] @niaid.nih.gov> wrote: I think Mark knows her well. She used to work with Praphan and Kiat. On Apr 18, 2020, at 7:10 PM, Jim Neaton @umn.edu> wrote: Thanks for the introduction Penny, and nice to meet you Jintanat. Look forward to talking to you on Wednesday and working on the protocols with you. Jim On Sat, Apr 18, 2020 at 4:43 PM Penny Heaton @gatesmri.org> wrote: Dear Cliff and Jim, Greetings! I hope this weekend finds you with at least a moment to relax. By way of this email, I would like to introduce you to Jintanat Ananworanich. She is a pediatrician and immunologist, currently co-leading our RSV monoclonal antibody program among others. She has much clinical trial experience, particularly in LMICs. She declares she has a some additional bandwidth and would love to join you on the weekly team calls and help in any way she can. I will leave it to the three of you to coordinate from here. Best, Penny